It has been four years since Congress enacted the Eliminating Kickbacks in Recovery Act (“EKRA”), codified at 18 U.S.C. § 220. EKRA initially targeted patient brokering and kickback schemes within the addiction treatment and recovery spaces. However, since EKRA was expansively drafted to also apply to clinical laboratories (it applies to improper referrals for any “service”, regardless of the payor), public as well as private insurance plans and even self-pay patients fall within the reach of the statute.
Blog Editors
Recent Updates
- Today’s Argument Was More Consequential Than Issued Opinions - SCOTUS Today
- Supreme Court Underscores Limited Applicability of Rule 10b-5(b) Omissions Claims
- Unanimity Among Justices Rules the Day - SCOTUS Today
- Pending Supreme Court Decision on the Constitutionality of the Consumer Financial Protection Bureau’s Funding Structure Results in Stay of Civil Investigative Demand
- The U.S. Sentencing Commission’s Proposed 2024 Amendments to the Federal Sentencing Guidelines Seek to Restore Consistency in Loss Calculations and Mitigate the Impact of Acquitted Conduct